The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling von Marr, Alexander R, Halpin, Madeline, Corbin, Dominique L, Asemelash, Yerdanos, Sher, Steven, Gordon, Britten K, Whipp, Ethan C, Mitchell, Shaneice, Harrington, Bonnie K, Orwick, Shelley, Benrashid, Samon, Goettl, Virginia M, Yildiz, Vedat, Mitchell, Andrew D, Cahn, Olivia, Mims, Alice S, Larkin, Karilyn T M, Long, Meixao, Blachly, James, Woyach, Jennifer A, Lapalombella, Rosa, Grieselhuber, Nicole R

Volltext

Additional file 1 of The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-caten... von Marr, Alexander R., Halpin, Madeline, Corbin, Dominique L., Asemelash, Yerdanos, Sher, Steven, Gordon, Britten K., Whipp, Ethan C., Mitchell, Shaneice, Harrington, Bonnie K., Orwick, Shelley, Benrashid, Samon, Goettl, Virginia M., Yildiz, Vedat, Mitchell, Andrew D., Cahn, Olivia, Mims, Alice S., Larkin, Karilyn T. M., Long, Meixao, Blachly, James, Woyach, Jennifer A., Lapalombella, Rosa, Grieselhuber, Nicole R.

Volltext bestellen

The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/[beta]-catenin signaling von Marr, Alexander R, Halpin, Madeline, Corbin, Dominique L, Asemelash, Yerdanos, Sher, Steven, Gordon, Britten K, Whipp, Ethan C, Mitchell, Shaneice, Harrington, Bonnie K, Orwick, Shelley, Benrashid, Samon, Goettl, Virginia M, Yildiz, Vedat, Mitchell, Andrew D, Cahn, Olivia, Mims, Alice S, Larkin, Karilyn T. M, Long, Meixao, Blachly, James, Woyach, Jennifer A, Lapalombella, Rosa, Grieselhuber, Nicole R

Volltext